| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.32 | 0.2 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.2 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |